UNITED KINGDOM – A new strategic partnership between Manchester University NHS Foundation Trust (MFT), Siemens Healthineers, and The University of Manchester (UoM) is set to accelerate Greater Manchester’s capacity to detect and diagnose health conditions disproportionately affecting the city’s population.

The Memorandum of Understanding (MoU) between Manchester University NHS Foundation Trust (MFT), Siemens Healthineers, and The University of Manchester (UoM), will formalize already close working relationships between the three organizations.

The MOU’s key priorities include earlier detection and intervention for cancer patients; data-driven approaches to early diagnosis; and integrative diagnostic approaches for the conditions disproportionately affecting the Greater Manchester population, such as heart disease and preventable cancers.

The partnership builds on an agreement in January 2021, when MFT and Siemens Healthineers confirmed a 15-year technology partnership with a value of approximately £125 million (US$135.8 million).

The Value Partnership between Siemens Healthineers and the Trust ensures the provision and replacement of key radiology equipment across nine of MFT’s hospitals.

This represents a strong investment in the future of the UK’s largest NHS trust and the 750,000 people it delivers care for.

In addition, MFT and The University of Manchester co-host the NIHR Manchester Biomedical Research Centre, which focuses on scientific breakthroughs in diagnostic tests and life-saving treatments.

Research infrastructure across Greater Manchester

Greater Manchester has one of the largest National Institute for Health and Care Research (NIHR) infrastructures in the country.

This includes the NIHR Manchester Clinical Research Facility, which was recently awarded increased funding to grow experimental medicine research across the city region during the next five years.

The GM research portfolio also encompasses the NIHR Manchester Biomedical Research Centre, co-hosted by MFT and UoM, which translates scientific breakthroughs into diagnostic tests and life-saving treatments.

Farther afield, Germany’s Siemens Healthineers announced strategic partnerships with HealthCare Global Enterprises, Narayana Health, and the Indian Institute of Science as part of its strategy to make India an innovation center for its global operations.

The medical technology company said the partnerships will focus on fighting the most threatening diseases, enabling efficient operations, and expanding access to patient care.

Siemens Healthineers Chief Technology Officer Peter Schardt said the partnership with HealthCare Global Enterprises Ltd (HCG) will focus on advancing cancer care with patient-centric solutions for the entire clinical pathway.

It will also look to enhance research on diagnostic imaging technologies, artificial intelligence, and precision therapy based on intelligent and image-guided treatment.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE